Dr. Ahlborn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2660 Main St
Bridgeport, CT 06606Phone+1 203-338-8760- Is this information wrong?
Summary
- Dr. David Ahlborn is a ABU Board Certified, Urologic Oncologist and the Director of Robotics for the Fairfield Region of HHC. He is affiliated with St Vincent's Medical Center in Bridgeport, CT. After graduating from Harvard College in 2011, he received his medical degree from Columbia University Vagelos College of Physicians and Surgeons in 2015. He trained at Mount Sinai Hospital in New York City and completed a fellowship in Urologic Oncology and Robotic Surgery at Hartford Hospital in 2020. He specializes in minimally invasive surgery and surgical oncology and is experienced in robotic urologic surgery and urology.
Education & Training
- Hartford HospitalFellowship, Urologic Surgical Oncology, 2020 - 2021
- Icahn School of Medicine at Mount SinaiResidency, Urology, 2016 - 2020
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Surgery, 2015 - 2016
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2015
- Harvard UniversityBA, Neurobiology, Cum Laude, 2007 - 2011
Certifications & Licensure
- NY State Medical License 2016 - 2025
- CT State Medical License 2020 - 2024
- American Board of Urology Urology
Publications & Presentations
PubMed
- What is the most effective way to ensure that patients successfully undergo germline testing for prostate cancer?David Ahlborn, Ilene Staff, Tara McLaughlin, Joseph Tortora, Joseph Wagner> ;Urologic Oncology. 2023 Jan 1
- 5 citationsMinimally invasive adrenal surgery: virtue or vice?Jared S. Winoker, David Ahlborn, Olamide Omidele, Gustavo Fernandez-Ranvier, Ithaar Derweesh, Reza Mehrazin> ;Future Oncology. 2018 Jan 18
- 7 citationsOncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance.Michael J. Whalen, Jamie S. Pak, Danny Lascano, David Ahlborn, Justin T. Matulay, James M. McKiernan, Mitchell C. Benson, Sven Wenske> ;Clinical Genitourinary Cancer. 2017 Oct 1
Professional Memberships
- American Urological AssociationMember
Hospital Affiliations
- St. Vincent's Medical CenterBridgeport, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: